Results 1,621-1,640 of 5,405 for speaker:Cathal Crowe

Written Answers — Department of Justice and Equality: Charitable and Voluntary Organisations (23 Nov 2021)

Cathal Crowe: 471. To ask the Tánaiste and Minister for Justice and Equality the way in which the new rule in relation to a lottery licence was communicated to organisations. [57162/21]

Written Answers — Department of Health: Medical Cards (23 Nov 2021)

Cathal Crowe: 662. To ask the Minister for Health if medical card holders must pay for blood tests carried out at their general practitioners; and if he will make a statement on the matter. [57472/21]

Written Answers — Department of Agriculture, Food and the Marine: Animal Passports (23 Nov 2021)

Cathal Crowe: 731. To ask the Minister for Agriculture, Food and the Marine the reason there is a delay in having passports for foals issued; and the actions he plans to take to address same. [57069/21]

Written Answers — Department of Justice and Equality: An Garda Síochána (24 Nov 2021)

Cathal Crowe: 142. To ask the Tánaiste and Minister for Justice and Equality when she expects the Garda training college in Templemore to intake its next group of recruits. [57699/21]

Joint Oireachtas Committee on Health: Delays in Accessing Scoliosis Treatment and Surgery: Discussion (11 Nov 2021)

Cathal Crowe: I thank the witnesses for being here today. I apologise as I have just come into the meeting in the past few moments. Since moving back to this building, we often dart between the Dáil Chamber and here. I have been following the meeting and reading the opening statements. I will begin where Professor McCormack left off just a moment ago. We heard there are theatres available and...

Joint Oireachtas Committee on Health: Delays in Accessing Scoliosis Treatment and Surgery: Discussion (11 Nov 2021)

Cathal Crowe: Could Professor McCormack estimate how prevalent its use is in Ireland?

Joint Oireachtas Committee on Health: Delays in Accessing Scoliosis Treatment and Surgery: Discussion (11 Nov 2021)

Cathal Crowe: It is important because not only are a number of young individuals grappling with scoliosis but when they got the magical treatment and underwent the implanting, they found a secondary problem leading to metallosis. It is extremely worrying. We are here to speak about surgery and how to get through the backlog. The medical professionals are doing fantastic work and are facing Mount...

Joint Oireachtas Committee on Health: Delays in Accessing Scoliosis Treatment and Surgery: Discussion (11 Nov 2021)

Cathal Crowe: My time is almost up but I thank Professor McCormack. A body of work must be done on this, although I realise it is tangential to what we are discussing today. It relates to scoliosis and is relevant for anybody who faces any form of orthopaedic surgery. There is a need to look at a regulatory regime that sounds very weak now. I suggest in future weeks we undertake a body of work on this...

Joint Oireachtas Committee on Health: Delays in Accessing Scoliosis Treatment and Surgery: Discussion (11 Nov 2021)

Cathal Crowe: I welcome Ms Hardiman and our other witnesses. We had Professor McCormack and Mr. Green with us a short while ago talking about their analysis of the waiting lists and the one thing they both said was that Covid-19 and the cyberattack cannot be blamed for the mess we are in regarding the long waiting list for scoliosis treatments and surgeries. One of the points that I homed in on was that...

Joint Oireachtas Committee on Health: Delays in Accessing Scoliosis Treatment and Surgery: Discussion (11 Nov 2021)

Cathal Crowe: I believe it was in CHI.

Joint Oireachtas Committee on Health: Delays in Accessing Scoliosis Treatment and Surgery: Discussion (11 Nov 2021)

Cathal Crowe: Okay. I am sorry. My apologies then-----

Joint Oireachtas Committee on Health: Delays in Accessing Scoliosis Treatment and Surgery: Discussion (11 Nov 2021)

Cathal Crowe: The point stands, but I am sorry. I understood that the situation was as I outlined it, but that is fine. Moving on, is Mr. Liam Woods with us as a witness?

Joint Oireachtas Committee on Health: Delays in Accessing Scoliosis Treatment and Surgery: Discussion (11 Nov 2021)

Cathal Crowe: My next question is linked to what we are talking about here. The Chair had a different view in the last session, but I ask for his forbearance now. In July this year, the Food and Drug Administration, FDA, in America issued a notice alerting patients and healthcare providers to the potential risk posed by MAGEC, that is, magnet expansion control, rods. The key concern referred to by the...

Joint Oireachtas Committee on Health: Delays in Accessing Scoliosis Treatment and Surgery: Discussion (11 Nov 2021)

Cathal Crowe: With the greatest of respect, I think every global media outlet has named this. I am not maligning any outlet.

Joint Oireachtas Committee on Health: Delays in Accessing Scoliosis Treatment and Surgery: Discussion (11 Nov 2021)

Cathal Crowe: I understand that.

Joint Oireachtas Committee on Health: Delays in Accessing Scoliosis Treatment and Surgery: Discussion (11 Nov 2021)

Cathal Crowe: I understand that and I would like to proceed because I will not be defaming anyone. I guarantee the Chair that. I will not be abusing privilege.

Joint Oireachtas Committee on Health: Delays in Accessing Scoliosis Treatment and Surgery: Discussion (11 Nov 2021)

Cathal Crowe: Can I proceed, because I am referencing something that is crucial to parents and patients here this morning?

Joint Oireachtas Committee on Health: Delays in Accessing Scoliosis Treatment and Surgery: Discussion (11 Nov 2021)

Cathal Crowe: I will continue because everything I am saying is already in the ether and has been covered by global media. This is a fact and it can found on Google in a matter of minutes.

Joint Oireachtas Committee on Health: Delays in Accessing Scoliosis Treatment and Surgery: Discussion (11 Nov 2021)

Cathal Crowe: Would you adjust the clock, Chair?

Joint Oireachtas Committee on Health: Delays in Accessing Scoliosis Treatment and Surgery: Discussion (11 Nov 2021)

Cathal Crowe: I will restart my question to Mr. Woods. There is a device that is manufactured in America. The FDA has in July of this year issued strong caution about it. It has alerted both patients and healthcare providers of the potential risk of this device. One of the key concerns it flagged is that the end caps of this device have a tendency to detach from the rest of the device. They detach...